Dr. Michael Lewiecki: "Healthy Bones, Medications and Common Sense" with Q & A

Dr. Michael Lewiecki, MD, FACP, FACE, CCD, FASBMR, top researcher, Director of New Mexico Clinical Research & Osteoporosis Center, prolific author of over 350 publications in peer reviewed medical journals (see below for full accolades) takes a deep dive into the many fascinating medication questions posed to him by his layperson audience, OsteoBoston members. Do not miss this fascinating, informative video. More about Dr. Lewiecki... E. Michael Lewiecki, MD, FACP, FACE, CCD, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. He is a consultant in osteoporosis and other metabolic bone diseases; supervisor and interpreter of bone density studies; clinical researcher; and educator. His research interests have been focused on evaluating new treatments for osteoporosis and rare bone diseases and developing technology-enabled communities of practice to expand capacity to deliver best practice skeletal health care worldwide. He has been principal investigator for many osteoporosis clinical trials and is author of over 350 publications in peer-reviewed medical journals with more than 31,000 citations, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and founding president of the Osteoporosis Foundation of New Mexico (OFNM). Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium. He is Review Editor for Osteoporosis International, and is on the editorial board of the Journal of Clinical Densitometry. Dr. Lewiecki has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation.